Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours
暂无分享,去创建一个
D. Strumberg | M. Scheulen | P. Rajagopalan | M. Buechert | K. Mross | A. Frost | S. Steinbild | O. Christensen | M. Ludwig | B. Schultheis | I. Adamietz | J. Kraetzschmar | Max E. Scheulen | K. Mross